Thoralf Christoffersen

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Kjell Magne Tveit, Tormod Kyrre Guren, Bengt Glimelius et al. · Journal of Clinical Oncology · 2012 · 527 citations

Binding of 125I-labeled glucagon and glucagon-stimulated accumulation of adenosine 3‘:5‘-monophosphate in isolated intact rat hepatocytes. Evidence for receptor heterogeneity.

O. Sonne, Trond Berg, Thoralf Christoffersen · Journal of Biological Chemistry · 1978 · 128 citations · Full text

Cellular Pharmacology, Receptor Heterogeneity, Adenosine 3 +19

Changes in hormone responsiveness and cyclic AMP metabolism in rat hepatocytes during primary culture and effects of supplementing the medium with insulin and dexamethasone

Thoralf Christoffersen, Magne Refsnes, Gunnar Brønstad et al. · European Journal of Biochemistry · 1984 · 98 citations · Full text

Development of cyclic AMP metabolism in rat liver a correlative study of tissue levels of cyclic AMP, accumulation of cyclic AMP in slices, adenylate cyclase activity and cyclic nucleotide phosphodiesterase activity

Thoralf Christoffersen, Jørg Mørland, J. B. Osnes et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 1973 · 83 citations

Biochemistry, Physiology, Cyclic Amp +3

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study

Tormod Kyrre Guren, Maria Thomsen, Elin H. Kure et al. · British Journal of Cancer · 2017 · 80 citations · Full text